Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Acta Ophthalmologica Scandinavica
|
February 13, 2001
A retrospective study of patients with retained nuclear fragments after cataract extraction
R B Olsson, J S Ritland, O M Bjørnsson, et al.
Clinical Chemistry
|
May 1, 1982
Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease
S Skrede, H E Solberg, S Ritland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
June 10, 1996
[Treatment of hepatitis C]
E Schrumpf, K Bjøro, H Bell, et al.
Cancer Research
|
May 15, 1993
Human epithelial ovarian cancer allelotype
W Cliby, S Ritland, L Hartmann, et al.
Mayo Clinic Proceedings
|
April 1, 1994
Aggressive medulloblastoma with high-level N-myc amplification
F H Tomlinson, R B Jenkins, B W Scheithauer, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1996
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
H Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology
|
March 28, 2002
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study
K Bjøro, H Bell, B Myrvang, et al.
Scandinavian Journal of Gastroenterology
|
March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
L M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Gastroenterology
|
April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
H Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
H Bell, K Hellum, S Harthug, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Acta Ophthalmologica Scandinavica
|
February 13, 2001
A retrospective study of patients with retained nuclear fragments after cataract extraction
R B Olsson, J S Ritland, O M Bjørnsson, et al.
Clinical Chemistry
|
May 1, 1982
Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease
S Skrede, H E Solberg, S Ritland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
June 10, 1996
[Treatment of hepatitis C]
E Schrumpf, K Bjøro, H Bell, et al.
Cancer Research
|
May 15, 1993
Human epithelial ovarian cancer allelotype
W Cliby, S Ritland, L Hartmann, et al.
Mayo Clinic Proceedings
|
April 1, 1994
Aggressive medulloblastoma with high-level N-myc amplification
F H Tomlinson, R B Jenkins, B W Scheithauer, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1996
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
H Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology
|
March 28, 2002
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study
K Bjøro, H Bell, B Myrvang, et al.
Scandinavian Journal of Gastroenterology
|
March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
L M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Gastroenterology
|
April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
H Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
H Bell, K Hellum, S Harthug, et al.
Page
of 11